Se requiere una suscripción a JoVE para ver este contenido. Inicie sesión o comience su prueba gratuita.
דור של תאי T CAR למאמצת תרפיה בהקשר של גליובלסטומה טיפול סטנדרטי
21,104 Views
•
12:55 min
•
February 16, 2015
DOI:
Summary
Automatically generated
The lymphodepletive and immunomodulatory effects of chemotherapy and radiation standard of care can be leveraged to enhance the antitumor efficacy of T cell immunotherapy. We outline a method for generating EGFRvIII-specific chimeric antigen receptor (CAR) T cells and administering them in the context of glioblastoma standard of care.
Read Article
Cite this Article
Riccione, K., Suryadevara, C. M., Snyder, D., Cui, X., Sampson, J. H., Sanchez-Perez, L. Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care. J. Vis. Exp. (96), e52397, doi:10.3791/52397 (2015).
Copy